Showing results (191-200 of 223) with videos related to

Sort By:
Pageof 23
Gut|September 1, 1992
Faecal unconjugated bile acids in patients with colorectal cancer or polypsC H Imray, S Radley, A Davis, et al.
The British Journal of Surgery|May 1, 1994
Unconjugated faecal bile acids in familial adenomatous polyposis analysed by gas-liquid chromatography and mass spectrometryG M Barker, S Radley, A Davis, et al.
Digestion|January 1, 1997
ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancerJ P Neoptolemos, D J Kerr, H Beger, et al.
The British Journal of Surgery|February 16, 2017
Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapyN T E Bird, M Elmasry, R Jones, et al.
BMJ (Clinical Research Ed.)|April 4, 1992
Predictive diagnosis of familial adenomatous polyposis with linked DNA markers: population based studyF MacDonald, D G Morton, P M Rindl, et al.
British Journal of Cancer|April 7, 2005
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancerD D Stocken, M W Büchler, C Dervenis, et al.
Lancet (London, England)|June 20, 2000
Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre studyJ P Neoptolemos, E A Kemppainen, J M Mayer, et al.
Langenbeck'S Archives of Surgery|November 22, 2019
The Liverpool duodenum-and spleen-preserving near-total pancreatectomy can provide long-term pain relief in patients with end-stage chronic pancreatitisA R G Sheel, R D Baron, L D Dickerson, et al.
The British Journal of Surgery|December 4, 2003
Increasing age and APACHE II scores are the main determinants of outcome from pancreatic necrosectomyS Connor, P Ghaneh, M Raraty, et al.
British Journal of Cancer|January 8, 2009
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trialsJ P Neoptolemos, D D Stocken, C Tudur Smith, et al.
Pageof 23